Effect of eslicarbazepine acetate on cognition in children with epilepsy

被引：0
|
作者：
Moreira, J. [1 ]
Pinto, R. [2 ]
Rocha, J. [1 ]
Soares-da-Silva, P. [1 ]
机构：
[1] BIAL Portela & Co SA, R&D, Sao Mamede do Coronado, Portugal
[2] Univ Porto, Fac Med, Oporto, Portugal
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2015年 / 357卷
关键词：
D O I：
10.1016/j.jns.2015.09.073
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1513
引用
收藏
页码：E439 / E439
页数：1
相关论文
共 50 条
  • [31] EFFECTS OF ESLICARBAZEPINE ACETATE IN THE AMYGDALA KINDLING MODEL OF TEMPORAL LOBE EPILEPSY
    Soerensen, J.
    Pekcec, A.
    Soares-da-Silva, P.
    Potschka, H.
    EPILEPSIA, 2009, 50 : 83 - 83
  • [32] Pharmacology of eslicarbazepine acetate in the amygdala kindling model of temporal lobe epilepsy
    Soerensen, J.
    Pekcec, A.
    Soares-da-Silva, P.
    Potschka, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 49 - 49
  • [33] A Review of Eslicarbazepine Acetate for the Adjunctive Treatment of Partial-Onset Epilepsy
    Singh, Rajinder P.
    Asconape, Jorge J.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 179 - 187
  • [34] Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
    Maia, Joana
    Almeida, L.
    Potgieter, J. H.
    Soares-da-Silva, P.
    EPILEPSIA, 2007, 48 : 337 - 337
  • [35] Long-term therapeutic effect of eslicarbazepine acetate in children: An open-label extension of a cognition study in children aged 6-16 years
    Veggiotti, Pierangelo
    Jozwiak, Sergiusz
    Kirkham, Fenella
    Moreira, Joana
    Pereira, Ana
    Ikedo, Fabio
    Gama, Helena
    EPILEPSY & BEHAVIOR, 2022, 127
  • [36] EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy
    Villanueva, V.
    Ojeda, J.
    Rocamora, R. A.
    Serrano-Castro, P. J.
    Parra, J.
    Rodriguez-Uranga, J. J.
    Bathal, H.
    Viteri, C.
    NEUROLOGIA, 2018, 33 (05): : 290 - 300
  • [37] Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
    Maia, J.
    Almeida, L.
    Falcao, A.
    Soares, E.
    Mota, F.
    Potgieter, M. A.
    Potgieter, J. H.
    Soares-da-Silva, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (03) : 119 - 130
  • [38] Anger, Mood and Quality of Life in Patients with Epilepsy Treated with Eslicarbazepine Acetate
    Toledo, M.
    Mazuela, G.
    Quintana, M.
    Cazorla, S.
    Mauri, J. A.
    Rodriguez-Osorio, X.
    Lopez-Gonzalez, F. J.
    Gomez-Eguilaz, M.
    Barcala, M.
    Esteve, P.
    Baiges, J. J.
    Abril-Jaramillo, J.
    Rodriguez-Uranga, J.
    Castro-Vilanova, M. D.
    Abraira del Fresno, L.
    Salas-Puig, J.
    Santamarina, E.
    EPILEPSIA, 2018, 59 : S271 - S271
  • [39] Effect of age and gender on the pharmacokinetics of eslicarbazepine acetate
    Soares-Da-Silva, P
    Almeida, L
    Falcao, A
    Maia, J
    EPILEPSIA, 2005, 46 : 216 - 217
  • [40] Potential efficacy and safety of eslicarbazepine acetate oral loading in patients with epilepsy
    Kwack, Dong Won
    Kim, Dong Wook
    EPILEPSIA, 2023, 64 (09) : E190 - E193
12345